1335 related articles for article (PubMed ID: 11371131)
21. High levels of p53 expression correlate with DNA aneuploidy in (pre)malignancies of the vulva.
van der Avoort IA; van de Nieuwenhof HP; Otte-Höller I; Nirmala E; Bulten J; Massuger LF; van der Laak JA; Slootweg PJ; de Hullu JA; van Kempen LC
Hum Pathol; 2010 Oct; 41(10):1475-85. PubMed ID: 20656324
[TBL] [Abstract][Full Text] [Related]
22. Squamous cell carcinoma of the vulva and adjacent lesions treated at Nagoya University Hospital from 1965 to 1997.
Akashi K; Nagasaka T; Nakashim N; Harada T; Okamoto T; Mizutani S; Ishiko H
Nagoya J Med Sci; 2001 Nov; 64(3-4):109-21. PubMed ID: 11820332
[TBL] [Abstract][Full Text] [Related]
23. [Epithelial changes associated with invasive epidermoid carcinoma of the vulva].
Tribbia G; Pezzica E; Buzzi A; Sonzogni A; Crescini C
Minerva Ginecol; 1995 Dec; 47(12):531-4. PubMed ID: 8720974
[TBL] [Abstract][Full Text] [Related]
24. Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesions.
Ferrandina G; Ranelletti FO; Salutari V; Gessi M; Legge F; Zannoni GF; Scambia G; Lauriola L
Gynecol Oncol; 2004 Feb; 92(2):537-44. PubMed ID: 14766245
[TBL] [Abstract][Full Text] [Related]
25. Protein markers of malignant potential in penile and vulvar lichen sclerosus.
Carlson BC; Hofer MD; Ballek N; Yang XJ; Meeks JJ; Gonzalez CM
J Urol; 2013 Aug; 190(2):399-406. PubMed ID: 23399649
[TBL] [Abstract][Full Text] [Related]
26. Invasive squamous cell carcinoma of vulva: prognostic significance of clinicopathologic parameters.
Nola M; Blazanovic A; Dotlic S; Morovic A; Tomicic I; Jukic S
Croat Med J; 2005 Jun; 46(3):436-42. PubMed ID: 15861524
[TBL] [Abstract][Full Text] [Related]
27. Differentiating vulvar intraepithelial neoplasia from nonneoplastic epithelial disorders. The toluidine blue test.
Joura EA; Zeisler H; Lösch A; Sator MO; Müllauer-Ertl S
J Reprod Med; 1998 Aug; 43(8):671-4. PubMed ID: 9749417
[TBL] [Abstract][Full Text] [Related]
28. Clinically identifying women with vulvar lichen sclerosus at increased risk of squamous cell carcinoma: a case-control study.
Jones RW; Sadler L; Grant S; Whineray J; Exeter M; Rowan D
J Reprod Med; 2004 Oct; 49(10):808-11. PubMed ID: 15568404
[TBL] [Abstract][Full Text] [Related]
29. P53 expression in vulvar carcinoma, vulvar intraepithelial neoplasia, squamous cell hyperplasia and lichen sclerosus.
Hantschmann P; Sterzer S; Jeschke U; Friese K
Anticancer Res; 2005; 25(3A):1739-45. PubMed ID: 16033093
[TBL] [Abstract][Full Text] [Related]
30. [Clinicopathological features of human papilloma virus associated squamous cell carcinomas of the vulva].
Guo L; Zhang L; Lian L
Zhonghua Fu Chan Ke Za Zhi; 1996 Sep; 31(9):551-4. PubMed ID: 9275429
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic analysis of 370 cases of vulvar intraepithelial neoplasia. Italian Study Group on Vulvar Disease.
J Reprod Med; 1996 Sep; 41(9):665-70. PubMed ID: 8887191
[TBL] [Abstract][Full Text] [Related]
32. Analysis of clonality and HPV infection in benign, hyperplastic, premalignant, and malignant lesions of the vulvar mucosa.
Ueda Y; Enomoto T; Miyatake T; Shroyer KR; Yoshizaki T; Kanao H; Ueno Y; Sun H; Nakashima R; Yoshino K; Kimura T; Haba T; Wakasa K; Murata Y
Am J Clin Pathol; 2004 Aug; 122(2):266-74. PubMed ID: 15323144
[TBL] [Abstract][Full Text] [Related]
33. Malignant potential of mixed vulvar dystrophy (lichen sclerosus associated with squamous cell hyperplasia).
Rodke G; Friedrich EG; Wilkinson EJ
J Reprod Med; 1988 Jun; 33(6):545-50. PubMed ID: 3404517
[TBL] [Abstract][Full Text] [Related]
34. The pathology of superficially invasive, thin vulvar squamous cell carcinoma.
Dvoretsky PM; Bonfiglio TA; Helmkamp BF; Ramsey G; Chuang C; Beecham JB
Int J Gynecol Pathol; 1984; 3(4):331-42. PubMed ID: 6511160
[TBL] [Abstract][Full Text] [Related]
35. p53 protein overexpression, a frequent observation in squamous cell carcinoma of the vulva and in various synchronous vulvar epithelia, has no value as a prognostic parameter.
Kagie MJ; Kenter GG; Tollenaar RA; Hermans J; Trimbos JP; Fleuren GJ
Int J Gynecol Pathol; 1997 Apr; 16(2):124-30. PubMed ID: 9100065
[TBL] [Abstract][Full Text] [Related]
36. Recurrent squamous cell carcinoma of the vulva: clinicopathologic determinants identifying low risk patients.
Preti M; Ronco G; Ghiringhello B; Micheletti L
Cancer; 2000 Apr; 88(8):1869-76. PubMed ID: 10760764
[TBL] [Abstract][Full Text] [Related]
37. Vulvar cancer.
Canavan TP; Cohen D
Am Fam Physician; 2002 Oct; 66(7):1269-74. PubMed ID: 12387439
[TBL] [Abstract][Full Text] [Related]
38. p53 protein expression in a population-based series of primary vulval squamous cell carcinoma and immediate adjacent field change.
McConnell DT; Miller ID; Parkin DE; Murray GI
Gynecol Oncol; 1997 Dec; 67(3):248-54. PubMed ID: 9441771
[TBL] [Abstract][Full Text] [Related]
39. Non-neoplastic epithelial alterations of the vulva: recognition assessment and comparisons of terminologies used among the various specialties.
Ambros RA; Malfetano JH; Carlson JA; Mihm MC
Mod Pathol; 1997 May; 10(5):401-8. PubMed ID: 9160302
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus, lichen sclerosus, and squamous cell carcinoma of the vulva: detection and prognostic significance.
Ansink AC; Krul MR; De Weger RA; Kleyne JA; Pijpers H; Van Tinteren H; De Kraker EW; Helmerhorst TJ; Heintz AP
Gynecol Oncol; 1994 Feb; 52(2):180-4. PubMed ID: 8314136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
